Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Your healthcare provider will typically prescribe the lowest dose first and gradually increase it over time
It features a C16 palmitic acid moiety conjugated to the Lys residue at the 26th position through a Glu residue
FDA status and availability timeline Neither cagrilintide nor retatrutide is currently FDA approved
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: insights from the SUSTAIN 17 trials
Generic competition is unlikely to meaningfully affect the GLP-1 market before 2030
A diuretic
US$ 23.26
US$ 22.71
US$ 26.45
US$ 24.67
US$ 20.82
